Show simple item record

dc.contributor.authorVansteenkiste, JF
dc.contributor.authorNaidoo, J
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorOzguroglu, M
dc.contributor.authorVillegas, A
dc.contributor.authorDaniel, D
dc.contributor.authorMurakami, S
dc.contributor.authorHui, R
dc.contributor.authorLee, KH
dc.contributor.authorCho, BC
dc.contributor.authorKubota, K
dc.contributor.authorTaboada, M
dc.contributor.authorWadsworth, C
dc.contributor.authorDennis, PA
dc.contributor.authorAntonia, SJ
dc.date.accessioned2019-12-09T17:23:31Z
dc.date.available2019-12-09T17:23:31Z
dc.date.issued2019en
dc.identifier.citationVansteenkiste JF, Naidoo J, Faivre-Finn C, Özgüroğlu M, Villegas A, Daniel D, et al. 1459PD Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC). Annals of Oncology. 2019;30(Supplement_5):592.en
dc.identifier.doi10.1093/annonc/mdz259.002en
dc.identifier.urihttp://hdl.handle.net/10541/622593
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz259.002en
dc.titleEfficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Respiratory Diseases, University Hospitals KU Leuven, Leuven, Belgiumen
dc.identifier.journalAnnals of Oncologyen
refterms.dateFOA2020-01-21T20:14:03Z


Files in this item

Thumbnail
Name:
mdz259.002.pdf
Size:
107.8Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract

This item appears in the following Collection(s)

Show simple item record